Navigation Links
Drugs That Shift Cell's Energy Find New Purpose
Date:2/15/2010

Researchers eye them as new treatments for heart disease, other conditions

MONDAY, Feb. 15 (HealthDay News) -- Researchers have identified several drugs that can change the way cells convert nutrients into energy, and they could potentially be used to treat heart attack, stroke and other conditions.

"Shifts in cells' energy production pathways take place naturally during development and in response to demanding activities -- like sprinting versus long-distance running. They are also known to be involved in several disease states," study leader Dr. Vamsi Mootha, of the Center for Human Genetic Research at Massachusetts General Hospital, said in a news release from the hospital.

"We wanted to identify compounds that can safely induce this shift -- those that have previously been discovered are too toxic -- and investigate their therapeutic potential in animal models," Mootha said.

Mootha and colleagues screened almost 3,700 compounds and pinpointed several U.S. Food and Drug Administration-approved drugs -- including an over-the-counter anti-nausea drug -- that can shift cellular energy.

The study was published Feb. 14 online in the journal Nature Biotechnology.

The findings may eventually lead to new treatments for some serious health problems, but much more research is needed, the researchers noted.

"Before we can think about human studies, we need to do rigorous animal testing to determine optimal, safe dosing regimens and learn more about how [these] drugs work," said Mootha, an assistant professor of systems biology at Harvard Medical School.

More information

The American Heart Association outlines heart attack treatments.



-- Robert Preidt



SOURCE: Massachusetts General Hospital, news release, Feb. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
2. Adapting to clogged airways makes common pathogen resist powerful drugs
3. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
4. The private sale of drugs in public hospitals
5. Glaucoma Drugs May Play Role in Longer Life
6. Rehabilitation for Opiate Addiction Without Maintenance Drugs
7. Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
8. Fake Drugs Bought on the Web Pose Big Health Risks
9. Scientists show how molecular switch helps pancreatic cancer beat drugs
10. Common antidepressant drugs linked to lactation difficulties in moms
11. Counterfeit Internet drugs pose significant risks and discourage vital health checks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: